Close
Patheon

Patheon Newsroom

  • 01 Feb 2017
    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, South Carolina...

  • 28 Nov 2016
    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    Patheon N.V. ("Patheon" or the "company") (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has signed a definitive agreement to acquire a state-of-the-art active...

  • 11 Oct 2016
    Company Commences Search for a New CFO

    Patheon N.V. (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, today announced that its executive vice president and chief financial officer, Stuart Grant, plans to retire in 2017...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

Patheon on Twitter

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

Patheon on Twitter